US · Healthcare

Argent BioPharma Limited (RGTLF)

Drug Manufacturers - Specialty & Generic

Argent BioPharma Limited (RGTLF) is listed on US in the Healthcare sector. Industry: Drug Manufacturers - Specialty & Generic. As of 2026-05-23, reported P/E ratio is 18.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.

Download on the App Store Get it on Google Play

Key metrics for RGTLF

P/E ratio

18.00

Argent BioPharma Limited (RGTLF) — FAQ

What is RGTLF's P/E ratio?

The price-to-earnings (P/E) ratio for Argent BioPharma Limited (RGTLF) is 18.00 (data as of 2026-05-23).

Does Argent BioPharma Limited pay a dividend?

Dividend yield is not available in the current snapshot for Argent BioPharma Limited (RGTLF). Check the MyAverix Finance app for the latest dividend data.

What sector is Argent BioPharma Limited in?

Argent BioPharma Limited (RGTLF) is classified in the Healthcare sector (Drug Manufacturers - Specialty & Generic industry).

What exchange is RGTLF listed on?

RGTLF is listed on US.

Full report in the app

Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.

Related Healthcare companies

Abbott Laboratories (ABT) AbbVie Inc. CDR (ABBV) Agilent Technologies Inc. (A1GI34) Aimed Bio (0009K0) Alnylam Pharmaceuticals, Inc. (A1LN34) Alvotech (ALVO) Amgen Inc (AMGN34) argenx SE (A1RG34)